Form 4 for GILD Gilead Sciences
Accepted 2026-03-12 00:00:00 ET · period of report 2026-03-10 · accession 0002110603-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-12 | 2026-03-10 | GILD | Cain Wettan Keeley M | EVP Gen Counsel, Legal, Comp | F - Tax | $148.56 | -606 | 5,054 | -11% | -$90.0K |
| D | 2026-03-12 | 2026-03-10 | GILD | Cain Wettan Keeley M | EVP Gen Counsel, Legal, Comp | M - OptEx | — | +1,246 | 5,660 | +28% | — |
| DM | 2026-03-12 | 2026-03-10 | GILD | Cain Wettan Keeley M | EVP Gen Counsel, Legal, Comp | A - Grant | $0.00 | +23.9K | 20.6K | New | $0 |
| D | 2026-03-12 | 2026-03-10 | GILD | Cain Wettan Keeley M | EVP Gen Counsel, Legal, Comp | M - OptEx | — | -1,246 | 15.5K | -7% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-10 | F | D | 606 | $148.56 | 5,054 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-10 | M | A | 1,246 | — | 5,660 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 3 | Derivative | Non-qualified Stock Option (Right to Buy) | 2026-03-10 | A | A | 18,885 | $0.00 | 18,885 | D | $148.56 · — to 2036-03-10 | 18,885 Common Stock | (F3) The stock options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 4 | Derivative | Restricted Stock Unit | 2026-03-10 | A | A | 5,050 | — | 20,586 | D | — · — to — | 5,050 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 5 | Derivative | Restricted Stock Unit | 2026-03-10 | M | D | 1,246 | — | 15,536 | D | — · — to — | 1,246 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |